Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load-Reference-Cited by-同舟云学术

Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load

Published:2013-05-03 Issue:2 Volume:58 Page:505-513
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Gordon Stuart C.¹,Krastev Zahary²,Horban Andrzej³,Petersen Jörg⁴,Sperl Jan⁵,Dinh Phillip⁶,Martins Eduardo B.⁶,Yee Leland J.⁶,Flaherty John F.⁶,Kitrinos Kathryn M.⁶,Rustgi Vinod K.⁷,Marcellin Patrick⁸

Affiliation:

1. Henry Ford Health SystemDetroitMI

2. University HospitalSt. Ivan RilskySofiaBulgaria

3. Warsaw Medical UniversityWarsawPoland

4. Liver Unit Asklepios Klinik St. GeorgHamburgGermany

5. Institute for Clinical and Experimental MedicinePragueCzech Republic

6. Gilead Sciences, Inc.Foster CityCA

7. Metropolitan Liver DiseasesFairfaxVA

8. Hôpital BeaujonUniversity of ParisClichyFrance

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.26277

Reference16 articles.

1. Changes in Serum Levels of HBV DNA and Alanine Aminotransferase Determine Risk for Hepatocellular Carcinoma

2. Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load

3. Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level

4. Factors That Predict Response of Patients With Hepatitis B e Antigen–Positive Chronic Hepatitis B to Peginterferon-Alfa

5. Effect of genotype and other baseline factors on response to peginterferon alfa‐2a (40 kDa) (Pegasys) in HBeAg‐positive chronic hepatitis B: results from a large, randomised study;Cooksley G;J Hepatol,2005

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Path to Cure Hepatitis B: How Far Are We?;Livestock Diseases and Management;2024

2. Association of tenofovir diphosphate and lamivudine triphosphate concentrations with HIV and hepatitis B virus viral suppression;AIDS;2023-11-22

3. Five-year results of a treatment program for chronic hepatitis B in Ethiopia;BMC Medicine;2023-09-29

4. Risk factors of low‐level viremia in chronic hepatitis B patients receiving Entecavir monotherapy: a retrospective cohort study;Journal of Gastroenterology and Hepatology;2023-09-17

5. Factors associated with persistent positive in HBV DNA level in patients with chronic Hepatitis B receiving entecavir treatment;Frontiers in Cellular and Infection Microbiology;2023-06-16